Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Remifentanil and Hyperalgesia: Gradual Withdrawal Versus Immediate Discontinuation

NCT03110653 is registered in ClinicalTrials.gov with Université Libre de Bruxelles as lead sponsor.

NCT NCT03110653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03110653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Remifentanil and Hyperalgesia: Gradual Withdrawal Versus Immediate Discontinuation
Lead sponsor
Université Libre de Bruxelles
Phase
Not applicable
Overall status
Completed
Start date
April 15, 2017
Completion date
August 30, 2017
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, pain